Results for tag: "Giant Cell Arteritis Drug"

Giant Cell Arteritis (GCA) is a type of vasculitis, or inflammation of the blood vessels, that primarily affects the arteries of the head and neck. It is a chronic condition that can cause severe headaches, vision loss, and jaw pain. Treatment for GCA typically involves the use of corticosteroids, such as prednisone, to reduce inflammation and prevent further damage to the arteries. In some cases, additional medications, such as methotrexate, may be prescribed to reduce the risk of relapse. The Giant Cell Arteritis Drug market is a subset of the larger Cardiovascular Drugs market. It includes medications used to treat GCA, as well as other drugs used to manage the symptoms of the condition. These drugs are typically prescribed by rheumatologists and other specialists. Some companies in the Giant Cell Arteritis Drug market include Pfizer, Novartis, Merck, and AbbVie. Show Less Read more